Research has identified genetic variations in young leukemia patients that are associated with an increased incidence of osteonecrosis, a serious cancer treatment side effect.
Research has identified genetic variations in young leukemia patients that are associated with an increased incidence of osteonecrosis, a serious cancer treatment side effect.